Leukos Biotech
PrivateLast Round
Debt
Oct 7, 2022
Total Funding Raised
$5.35M
Company Overview
Leukos Biotech is a biopharmaceutical company that develops innovative therapies and diagnostic tools for hematological malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leukos Biotech Comparables
Compare Leukos Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncostellae | 78% | |
| Pacylex Pharmaceuticals | 73% | |
| OneChain Immunotherapeutics | 73% |
Leukos Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 7, 2022 | ||||
| VC Round | Dec 31, 2018 | ||||
| Grant | May 1, 2018 | ||||
| Seed | Sep 21, 2016 | ||||
| Grant | Jan 1, 2016 |
Key People
Founding team and executive leadership
Leukos Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| CDTI Innvierte | Seed |
| Ministerio de Economía, Comercio y Empresa | Grant |
| Inveready | VC Round, Seed |
| Spanish Government (Ministry of Science) | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2022
$790K round from the Spanish Government.
- Sep 21, 2016
$4M round led by Inveready
Leukos Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Leukos Biotech's valuation, stock price, and market status.
Is Leukos Biotech a public or private company?
Leukos Biotech is a private company.
What is the current stock price of Leukos Biotech?
Leukos Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Leukos Biotech worth (valuation)?
Valuation information for Leukos Biotech is not publicly available.
Can I buy Leukos Biotech stock?
Leukos Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Leukos Biotech's last funding round?
Leukos Biotech's most recent funding round was Debt on October 7, 2022.
Who are the main investors in Leukos Biotech?
Key investors in Leukos Biotech include Inveready.
Will Leukos Biotech IPO soon?
No public IPO plans have been announced for Leukos Biotech.
How can I track Leukos Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Leukos Biotech's secondary market activity and sign up for updates.